A document related to the project entitled Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: Clinical and Economic Impact of Standard Versus Extended Duration is now available for feedback from all interested stakeholders.
Project
Call for Feedback
Feedback Due By
Dual Antiplatelet Therapy Following Percutaneous Coronary In...
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website.
filgrastim
Brand name
Generic name
Manufacture...
April 14, 2019 - April 16, 2019
CADTH will be hosting its annual Symposium at the Shaw Centre in Edmonton, Alberta, from April 14 to 16, 2019.
For more information, please visit the CADTH Symposium website. Questions may be sent by email to symposium@cadth.ca.
